NK/T-CELL LYMPHOMA

Clinical trials for NK/T-CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new NK/T-CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for NK/T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 3 Not yet finished but already full! 1 Completed 1 Terminated 1

New drug combo tested for Tough-to-Treat blood cancers

Disease control Terminated

This study tested whether adding a drug called selinexor to standard chemotherapy or an immunotherapy drug (tislelizumab) could help control advanced T-cell and NK-cell lymphomas that had returned or stopped responding to prior treatments. It involved adults whose cancer had come…

Matched conditions: NK/T-CELL LYMPHOMA

Phase: PHASE1, PHASE2 • Sponsor: Antengene Corporation • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

NK/T-CELL LYMPHOMA

Get alerted when new NK/T-CELL LYMPHOMA trials appear

New drug combo tested for Tough-to-Treat blood cancers